Evidence map›Paper›PMID 31050218›Full record

ArticleCancer medicine2019

Combination of preoperative plasma fibrinogen and AJCC staging improves the accuracy of survival prediction for patients with stage I-II gastric cancer after curative gastrectomy.

Peng Ding, Chen Zheng, Guohui Cao, Ziming Gao, Yuying Lei, Peng Deng, Bin Hou, Kai Li

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. A functional NKILA variant (rs2273534) drives genetic susceptibility and oncogenic progression in gastric cancer via the miR-4424/OAS2 pathway.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2026
    Article
  3. The impact of ADAMTS14 genetic polymorphisms and its function on susceptibility to and prognosis of gastric cancer in a Chinese Han population.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Peng DingDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.ORCID 0000-0001-5849-8364
Chen ZhengDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Guohui CaoDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Ziming GaoDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Yuying LeiDepartment of Oncology, The Hebei Province General Hospital, Shijiazhuang, China.
Peng DengDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Bin HouDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Kai LiDepartment of Surgical Oncology and General Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
First Hospital of China Medical University · CNHebei General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determine the prognostic value of preoperative plasma fibrinogen concentration (PFC) in patients with stage I-II gastric cancer after curative gastrectomy. The preoperative PFC and clinicopathological data of 793 patients with stage I-II gastric cancer who underwent curative gastrectomy were analyzed retrospectively. PFC of <4.0 g/L and ≥4.0 g/L were considered as PFC0 and PFC1, respectively. The association between PFC and the clinicopathological features of gastric cancer and the value of PFC in survival prediction were investigated. PFC1 indicated poorer overall survival and cancer-specific survival among patients with tumor-node-metastasis (TNM) stage I-II, and PFC was identified as an independent indicator of survival via multivariate analysis. Importantly, PFC stage was proven to be an independent prognostic factor for stage I and T1-4aN0 gastric cancer. PFC stage combined with the American Joint Committee on Cancer (AJCC)-TNM stage has better accuracy for predicting disease prognosis than AJCC-TNM stage alone. The prognosis of patients with stage I-II gastric cancer can be further stratified by PFC level. For patients with stage I gastric cancer, PFC1 can be considered a high-risk prognostic factor, and adjuvant chemotherapy should be recommended for patients with PFC1.

Indexed as

Chemotherapy, AdjuvantFemaleFibrinogenGastrectomyHumansMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesStomach NeoplasmsSurvival AnalysisFibrinogenfibrinogengastric cancerprognosisstaging

Identifiers

PMID31050218
PMCPMC6558503
OpenAlexW2942559600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.